Lung Cancer

Tecemotide (INN; emepepimut-S (USAN); formerly known as BLP25 or EMD 531444) is a synthetic lipopeptide that is used as antigen in an investigational therapeutic cancer vaccine (formerly known as Stimuvax, L-BLP25, BLP25 liposomal vaccine, or BLP25 liposome vaccine).

Read more in the app

Eat better, breathe easier? Research points to link between diet, lung cancer - EurekAlert

Eat better, breathe easier? Research points to link between diet, lung cancer

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation - EurekAlert

Lung Cancer Is Rising in Non-Smokers, And This Could Be Why

Research pinpoints weakness in lung cancer's defenses

Copper-detection tool designed to discover possible chelation target for lung cancer

Princeton Chemistry develops copper-detection tool to discover possible chelation target for lung cancer - EurekAlert

Chinese Medical Journal article sheds light on the global lifetime risk of lung cancer - EurekAlert

Fibroblastic reticula cells can organize T cells in the fight against lung cancer

Signs of Lung Cancer Can Now Be Detected When You Exhale

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer - EurekAlert

Scientists use microcellular drones to deliver lung cancer-killing drugs - EurekAlert

Scientists use microcellular drones to deliver lung cancer-killing drugs

Detecting evidence of lung cancer in exhaled breath

Detecting evidence of lung cancer in exhaled breath - EurekAlert

New Subtype of Lung Cancer Discovered in Young, Non-Smoking Patients

Lung Cancer: Researchers Find Three Subtypes of Tumors in People That Never Smoked

Study links methylmalonic acid to weakening of immune cells in lung cancer

Dual immunotherapy plus chemotherapy benefits specific subset of patients with lung cancer

Dual immunotherapy plus chemotherapy benefits specific subset of patients with lung cancer - EurekAlert